Tag: post-approval drug monitoring
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
How to Discuss Deprescribing Goals with Your Doctor: A Guide for Seniors
Jun, 18 2026
Noni: Unlocking Polynesian Secrets for Health and Wellness
May, 9 2024
Chest Pain Evaluation: When to Go to the Emergency Department
Jan, 13 2026
Drug Take-Back Programs in Your Community: How They Work
Jun, 3 2026
Chinese Generic Production: Manufacturing and Quality Concerns in 2026
Jan, 10 2026